Redeye updates its estimates on the back of I-Tech’s Q3’22 report, beating our estimates again. In this update, we increase our expectations on profitability for Q4’22 as well as 2023-2024. Also, we add some notes regarding the recent market development.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking.
